Litcius/Paper detail

Successful treatment with dupilumab for mucus plugs in severe asthma

Moriyasu Anai, Chieko Yoshida, Hiroki Izumi, Kei Muramoto, Koichi Saruwatari, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami

2022Respirology Case Reports21 citationsDOIOpen Access PDF

Abstract

A 29-year-old man presented to our hospital with severe eosinophilic asthma. He needed a short OCS burst for exacerbation of asthma once every 1 or 2 months, although he used a high dose of inhaled corticosteroids and a long-acting beta-2 agonists. Chest CT showed multiple mucous plugs with bronchiectasis, but further examination found that he did not meet the diagnostic criteria for allergic bronchopulmonary aspergillosis. After starting dupilumab for his severe eosinophilic asthma, his asthma control improved without exacerbation. Furthermore, most mucus plugs disappeared on chest CT after 16 weeks from initiating dupilumab. This case suggests that dupilumab may be an effective treatment against mucus plugs associated with severe eosinophilic asthma.

Topics & Concepts

DupilumabMedicineExacerbationAllergic bronchopulmonary aspergillosisBronchiectasisAsthmaEosinophilicMucusImmunologyInternal medicineImmunoglobulin ELungPathologyAntibodyBiologyEcologyAsthma and respiratory diseasesRespiratory and Cough-Related ResearchChronic Obstructive Pulmonary Disease (COPD) Research